Zeng Haiping, Wang Jun, Deng Runpei, Chen Zhiqiang
The Second School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510405, People's Republic of China.
Department of Urology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, People's Republic of China.
Onco Targets Ther. 2020 Dec 21;13:13015-13022. doi: 10.2147/OTT.S283704. eCollection 2020.
Primary urethral non-Hodgkin's lymphoma (NHL) is uncommon. This case study reports the case of a 52-year-old woman with a light red mass at the urethral orifice. Her clinical manifestations included frequent urination, urgency, dysuria, and occasionally blood in urine. The tumor was surgically removed, and the pathological and immunohistochemistry examination confirmed the presence of a diffuse large B-cell lymphoma (DLBCL). Examination using positron emission tomography/computed tomography (PET/CT) revealed multiple hypermetabolic lymph nodes next to the external iliac vessels and bilateral inguinal regions, and focal hypermetabolic lesions in the vulvar nodules (consistent with the changes caused by lymphoma infiltration). Eight cycles of chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (R-CHOP) were prescribed after surgery. Re-examination using PET/CT showed lack of hypermetabolic tumor recurrence signs, and the presence of multiple slightly large lymph nodes in the lateral iliac vessels and inguinal regions, but without significant lymph node metabolism increases. To date, only fifteen cases of primary diffuse large B-cell lymphoma of the urethra (including this one) have been reported in the literature. Therefore, we reviewed the etiology, clinical manifestations, diagnosis, differential diagnosis, treatment, and prognosis of DLBCL based on the existing literature to help characterize this rare disease.
原发性尿道非霍奇金淋巴瘤(NHL)较为罕见。本病例报告了一名52岁女性,其尿道口有淡红色肿物。她的临床表现包括尿频、尿急、尿痛,偶尔伴有血尿。肿瘤通过手术切除,病理及免疫组化检查确诊为弥漫性大B细胞淋巴瘤(DLBCL)。正电子发射断层扫描/计算机断层扫描(PET/CT)检查显示,髂外血管旁及双侧腹股沟区有多个代谢增高的淋巴结,外阴结节有局灶性代谢增高病变(符合淋巴瘤浸润所致改变)。术后给予利妥昔单抗、环磷酰胺、多柔比星、长春新碱和地塞米松(R-CHOP)方案化疗8个周期。PET/CT复查显示无代谢增高的肿瘤复发征象,髂外血管外侧及腹股沟区有多个稍大的淋巴结,但淋巴结代谢无明显增高。迄今为止,文献中仅报道了15例原发性尿道弥漫性大B细胞淋巴瘤(包括本病例)。因此,我们根据现有文献对DLBCL的病因、临床表现、诊断、鉴别诊断、治疗及预后进行了综述,以助于对这种罕见疾病进行特征描述。